1992
DOI: 10.1378/chest.101.4.1000
|View full text |Cite
|
Sign up to set email alerts
|

Long-term Sequelae after Recovery from Cytomegalovirus Pneumonia in Allogeneic Bone Marrow Transplant Recipients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0
1

Year Published

1994
1994
2019
2019

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 8 publications
0
3
0
1
Order By: Relevance
“…1,2 In the bone marrow transplant population, CMV infection has been correlated with the subsequent development of pulmonary abnormalities in long-term survivors. 3 CMV infection has also been shown to enhance the degree of graft versus host disease after bone marrow transplant. 4,5 This has been demonstrated clearly in animal models and has been shown as an association in humans.…”
Section: Introductionmentioning
confidence: 99%
“…1,2 In the bone marrow transplant population, CMV infection has been correlated with the subsequent development of pulmonary abnormalities in long-term survivors. 3 CMV infection has also been shown to enhance the degree of graft versus host disease after bone marrow transplant. 4,5 This has been demonstrated clearly in animal models and has been shown as an association in humans.…”
Section: Introductionmentioning
confidence: 99%
“…Although there have been several studies evaluating the risk of developing CMV pneumonia [7][8][9][10], there is very limited information on factors that determine outcome of CMV pneumonia [11]. There have been no randomized trials evaluating the treatment for CMV pneumonia.…”
mentioning
confidence: 99%
“…Chien et al describe seven BMT recipients, after CMV pneumonia. Five patients died, in the remaining two restrictive lung disease with lower DLCO was diagnosed [25]. Also, in kidney transplant recipients, CMV caused subclinical pulmonary dysfunction with pulmonary diffusion disturbances some months after active disease treatment [26].…”
Section: Discussionmentioning
confidence: 99%